Approximately 15 million people worldwide have a stroke each year, and clinical monitoring after a stroke is critical for early detection of secondary strokes. In this episode, we hear more about the start-up company Nuroflux from Sam van Bohemen, Co-founder, CEO, and CTO. Nuroflux is part of the Remarkable Accelerator Program, and they are creating a wearable system that provides continuous, quantitative monitoring of blood flow and activity in the brain for use in people after a stroke. Later in this episode, David Smith shares insights about his stroke and recovery before Nuroflux was created. He discusses his experience and how he thinks Nuroflux could help others who have a stroke in the future.

Support CPARF: https://cparf.salsalabs.org/give/index.html